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A 2-year-old boy born of a non-consanguineous marriage
was admitted with a history of failure to thrive and motor-
development delay since birth. He had polyuria, polydipsia,
and constipation. On examination, his weight and height
were below the third centile for age. He had a widely open
anterior fontanelle with clinical features of rickets including
gross bony deformities and bony tenderness. Abdominal
examination revealed nodular hepatomegaly, with a liver
span of 8 cm and splenomegaly of 3 cm below the left costal
margin (Figure 1).
Investigations revealed hyperchloremic metabolic acidosis
with normal anion gap and hypokalemia. Urinalysis revealed
aminoaciduria, phosphaturia, and glycosuria. Liver functions
were within normal limits. X-ray of the limbs showed
multiple healing fractures. Ultrasound showed normal-sized
kidneys without nephrocalcinosis and hepatomegaly with
multiple hyperechoic nodules in the liver. Computed
tomography of the abdomen showed enlarged liver with
multiple non-enhancing lesions. His alpha-feto-protein levels
were elevated (935 ng/ml).
Liver biopsy was done, which showed loss of architecture
of the liver with pseudolobules separated by fibrous septae.
The hepatocytes showed microvesicular fatty change. The
fibrous septae showed a chronic inflammation infiltrate with
piecemeal necrosis. Ductular proliferation was prominent.
Kupffer cells were unremarkable.
What is your diagnosis?
How will you confirm the diagnosis?
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Figure 1 |Clinical photograph showing
hepatosplenomegaly and rickets.
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The Diagnosis | Tyrosinemia, type I
Tandem mass spectrometry showed low blood-free and
acyl carnitines. Amino-acid qualitative analysis of urine showed
significantly elevated levels of tyrosine. Analysis of plasma
showed a tyrosine level of 232mmol/l (normal 30–100mmol/l).
Urine succinylacetone level was 8.2mmol/l (normalo1mmol/l).
A diagnosis of tyrosinemia type I was established.
Tyrosinemias are characterized by the accumulation of
tyrosine in the body. The most severe form, type I, is a
disorder that causes liver failure, painful neurologic crises,
Fanconi’s syndrome, and hepatocellular carcinoma. It is
caused by a deficiency of fumarylacetoacetate hydrolase
(Figure 2). Oculocutaneous tyrosinemia, type II, is caused
by a deficiency of tyrosine aminotransferase. Tyrosinemia
type III is a rare disorder caused by a deficiency of
4-hydroxyphenylpyruvic dioxygenase and presents with
ataxia and mental retardation.1 These disorders are diagnosed
by the presence of elevated tyrosine by plasma amino-acid
chromatography and tyrosine metabolites by urine organic
acid analysis. Urine shows elevated p-hydroxy-phenyl organic
acids in all types of tyrosinemia, and the pathog-
nomic succinylacetone in tyrosinemia type I.2 Diagnosis
can be confirmed by enzyme or molecular studies in tyrosi-
nemia type I. Therapy consists of a diet low in phenylalanine
and tyrosine. For tyrosinemia type I, 2-(2-nitro-4-trifluoro-
methylbenzoyl)-1,3-cyclohexanedione can be used.1
Tyrosinemia type I is of autosomal recessive inheritance. It
has a prevalence of about 1 in 100,000 newborns. It is charac-
terized by progressive liver disease and Fanconi’s syndrome.
It occurs in an acute and a chronic form. Hepatocellular
carcinoma is frequently encountered in the chronic form
of the disorder.2 The enzyme defect results in accumulation of
fumaryl- and maleyl-acetoacetate, which cause cellular damage.
Succinylacetone, derived from these metabolites, is elevated in
the serum and urine of these patients. The diagnosis can be
established by determination of succinylacetone in urine or
serum and by assay of fumaryl acetoacetate hydrolase in
lymphocytes and fibroblasts. Prenatal diagnosis is possible by
analysis of succinylacetone in amniotic fluid and by fumaryl-
acetoacetate hydrolase assay in cultured amniotic fluid cells or
chorionic villus material. Liver transplantation is as yet the only
definite treatment for this disorder.3
In a child who presents with features of proximal renal
tubular acidosis along with hepatosplenomegaly, inborn errors
of metabolism need to be considered. Glycogen storage
disorders like Von Gierke’s and Fanconi–Bickel syndrome along
with tyrosinemia are the important differential diagnosis.
Hypoglycemia and hyperlipidemia are important markers of
Von Gierke’s and Fanconi–Bickel syndrome. These glycogen
storage disorders show glycogen deposits on liver biopsy.
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Figure 2 |Pathway showing defect in metabolism of tyrosine
in tyrosinemia type 1.
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